ARCHIVES

ACS Recommends MRI For Some Women At High Risk

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Sept. Is AMA’s Month of Women In Medicine

September 10, 1993

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

CCOP RFA Issued; ‘Chop-Like’ Elements Permitted But Not Required; No ‘Cap’; Consortia Allowed

July 16, 1982

New Approaches To Improve Diagnoses In Urogenital Cancers Presented At AUA

September 24, 2004

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001